SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: DewDiligence_on_SI who wrote (367)2/10/2006 3:13:06 AM
From: DewDiligence_on_SI  Respond to of 447
 
I reread ACL’s PR from 12/12/05 and it states that the drug to be tested with Retaane is indeed intravitreal Avastin. Thus, I am baffled by ACL’s coyness on yesterday’s CC in not referring to Avastin by name.